<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(10)</volume><submitter>Katsuki T</submitter><funding>Takeda Science Foundation</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Bayer</funding><funding>MSD</funding><pubmed_abstract>Inappropriate endothelial cell (EC) interactions contribute to heart failure; however, their precise mechanisms remain poorly understood. This study investigated EC-fibroblast interactions mediated by Scarb1 using single-cell RNA-sequencing analysis in a mouse heart failure model. ECs exhibited inflammatory and fibrotic gene expression, with Scarb1-mediated fibroblast-EC interactions driving disease progression. EC-specific Scarb1 knockout and systemic SCARB1 inhibition attenuated heart failure progression. In vitro and spatial omics analyses confirmed the role of SCARB1 in ECs and cell-cell interaction during heart failure progression. These findings highlight SCARB1 as a promising therapeutic target for EC-focused interventions.</pubmed_abstract><journal>JACC. Basic to translational science</journal><pagination>101308</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12665495</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inhibition of Scarb1 on Endothelial Cells Attenuates Pressure Overload-Induced Heart Failure Progression.</pubmed_title><pmcid>PMC12665495</pmcid><pubmed_authors>Kuramoto J</pubmed_authors><pubmed_authors>Fukuda K</pubmed_authors><pubmed_authors>Komuro J</pubmed_authors><pubmed_authors>Katsuki T</pubmed_authors><pubmed_authors>Kubota Y</pubmed_authors><pubmed_authors>Ieda M</pubmed_authors><pubmed_authors>Miyasaka M</pubmed_authors><pubmed_authors>Kimura M</pubmed_authors><pubmed_authors>Kusumoto D</pubmed_authors><pubmed_authors>Akiba Y</pubmed_authors><pubmed_authors>Suzuki Y</pubmed_authors><pubmed_authors>Yuasa S</pubmed_authors><pubmed_authors>Nakamura T</pubmed_authors><pubmed_authors>Kouka T</pubmed_authors><pubmed_authors>Sugai K</pubmed_authors><pubmed_authors>Katsumata Y</pubmed_authors><pubmed_authors>Hashimoto H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of Scarb1 on Endothelial Cells Attenuates Pressure Overload-Induced Heart Failure Progression.</name><description>Inappropriate endothelial cell (EC) interactions contribute to heart failure; however, their precise mechanisms remain poorly understood. This study investigated EC-fibroblast interactions mediated by Scarb1 using single-cell RNA-sequencing analysis in a mouse heart failure model. ECs exhibited inflammatory and fibrotic gene expression, with Scarb1-mediated fibroblast-EC interactions driving disease progression. EC-specific Scarb1 knockout and systemic SCARB1 inhibition attenuated heart failure progression. In vitro and spatial omics analyses confirmed the role of SCARB1 in ECs and cell-cell interaction during heart failure progression. These findings highlight SCARB1 as a promising therapeutic target for EC-focused interventions.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-06T15:02:17.269Z</modification><creation>2026-06-01T03:10:37.553Z</creation></dates><accession>S-EPMC12665495</accession><cross_references><pubmed>40772900</pubmed><doi>10.1016/j.jacbts.2025.05.003</doi></cross_references></HashMap>